A new drug, PIPE-307, shows promise in reversing multiple sclerosis (MS) damage by promoting myelin regeneration around nerve cells, potentially restoring movement and function. Developed by researchers, this innovative therapy targets a specific receptor, M1R, and has already demonstrated success in animal models. PIPE-307 is currently in Phase II clinical trials, offering hope for a groundbreaking treatment that could stop and even heal the damage caused by MS. This novel approach could transform the future of MS therapy by addressing both symptoms and underlying damage.

A new study links diets rich in vitamins and minerals, with low added sugar, to younger biological age. Researchers found that healthier diets correlated with a younger epigenetic clock, even accounting for each gram of added sugar. The study is one of the first to show this link in a diverse group of midlife women. Findings highlight the importance of reducing sugar intake for better health and longevity.